<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Merck &amp; Company</title>
    <link>https://www.biospace.com/employer/401028/merck-company</link>
    <description>Merck &amp; Company</description>
    <language>en-US</language>
    <lastBuildDate>Mon, 21 Jun 2021 17:04:10 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/401028/merck-company.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>HHS Withdraws Advisory Opinion on 340B Drug Discount Program</title>
      <link>https://www.biospace.com/hhs-withdraws-advisory-opinion-on-340b-drug-discount-program</link>
      <dc:creator>Mark Terry</dc:creator>
      <description>This program limits the prices drug manufacturers can charge for therapies sold to specific healthcare facilities, including public hospitals and community health centers.</description>
      <pubDate>Mon, 21 Jun 2021 17:04:10 GMT</pubDate>
      <guid>https://www.biospace.com/hhs-withdraws-advisory-opinion-on-340b-drug-discount-program</guid>
    </item>
    <item>
      <title>CG Oncology Teams with Merck, BMS for Positive Bladder Cancer Results</title>
      <link>https://www.biospace.com/cg-oncology-teams-with-merck-bms-for-promising-bladder-cancer-results</link>
      <dc:creator>Alex Keown</dc:creator>
      <description>A combination study of CG Oncology’s oncolytic immunotherapy and a checkpoint inhibitor is showing promise.</description>
      <pubDate>Mon, 06 Jun 2022 15:59:31 GMT</pubDate>
      <guid>https://www.biospace.com/cg-oncology-teams-with-merck-bms-for-promising-bladder-cancer-results</guid>
    </item>
    <item>
      <title>FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA® (olaparib) as Adjuvant Treatment in BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer and Grants Priority Review</title>
      <link>https://www.biospace.com/fda-accepts-regulatory-submission-of-supplemental-new-drug-application-for-lynparza-olaparib-as-adjuvant-treatment-in-brca-mutated-her2-negative-high-risk-early-breast-cancer-and-grants-priority-review</link>
      <description>FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA ® (olaparib) as Adjuvant Treatment in BRCA -Mutated, HER2-Negative High-Risk Early Breast Cancer and Grants Priority Review.</description>
      <pubDate>Tue, 30 Nov 2021 11:36:06 GMT</pubDate>
      <guid>https://www.biospace.com/fda-accepts-regulatory-submission-of-supplemental-new-drug-application-for-lynparza-olaparib-as-adjuvant-treatment-in-brca-mutated-her2-negative-high-risk-early-breast-cancer-and-grants-priority-review</guid>
    </item>
    <item>
      <title>Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet</title>
      <link>https://www.biospace.com/b-schering-plough-merck-pharmaceuticals-b-announce-fda-filing-acceptance-of-new-drug-application-for-loratadine-montelukast-tablet</link>
      <description />
      <pubDate>Tue, 28 Aug 2007 16:21:15 GMT</pubDate>
      <guid>https://www.biospace.com/b-schering-plough-merck-pharmaceuticals-b-announce-fda-filing-acceptance-of-new-drug-application-for-loratadine-montelukast-tablet</guid>
    </item>
    <item>
      <title>Merck &amp; Co., Inc. (Jobs) Announces FDA Acceptance of NDA for CORDAPTIVE(TM) (ER niacin/laropiprant), Formerly Known as MK-0524A, an Investigational Lipid-Modifier</title>
      <link>https://www.biospace.com/merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-248338-font-color-1c488f-jobs-font-a-165151</link>
      <description />
      <pubDate>Wed, 29 Aug 2007 15:55:50 GMT</pubDate>
      <guid>https://www.biospace.com/merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-248338-font-color-1c488f-jobs-font-a-165151</guid>
    </item>
    <item>
      <title>Mylan Laboratories Inc. Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck &amp; Co., Inc.'s Generic Pharmaceutical Business</title>
      <link>https://www.biospace.com/mylan-laboratories-inc-commences-tender-offers-and-consent-solicitations-for-its-5-750-percent-senior-notes-due-2010-and-6-375-percent-senior-notes-due-2015-in-con</link>
      <description />
      <pubDate>Fri, 31 Aug 2007 18:59:35 GMT</pubDate>
      <guid>https://www.biospace.com/mylan-laboratories-inc-commences-tender-offers-and-consent-solicitations-for-its-5-750-percent-senior-notes-due-2010-and-6-375-percent-senior-notes-due-2015-in-con</guid>
    </item>
    <item>
      <title>Merck &amp; Co., Inc. (Jobs) Halts Study of "Ineffective" HIV Vaccine</title>
      <link>https://www.biospace.com/merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-130024-jobs-a-halts-study-of-ineffective</link>
      <description />
      <pubDate>Mon, 24 Sep 2007 15:45:54 GMT</pubDate>
      <guid>https://www.biospace.com/merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-130024-jobs-a-halts-study-of-ineffective</guid>
    </item>
    <item>
      <title>Merck &amp; Co., Inc. (Jobs) Drug Dramatically Lifts Good Cholesterol</title>
      <link>https://www.biospace.com/merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-351976-jobs-a-drug-dramatically-lifts-good</link>
      <description />
      <pubDate>Fri, 05 Oct 2007 16:58:32 GMT</pubDate>
      <guid>https://www.biospace.com/merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-351976-jobs-a-drug-dramatically-lifts-good</guid>
    </item>
    <item>
      <title>GTx, Inc. and Merck &amp; Co., Inc. in Drug Venture to Treat Age-Related Muscle Loss; GTx to Receive $40 Million Upfront</title>
      <link>https://www.biospace.com/gtx-inc-and-merck-and-co-inc-in-drug-venture-to-treat-age-related-muscle-loss-b-gtx-b-to-receive-40-million-upfront</link>
      <description />
      <pubDate>Tue, 06 Nov 2007 16:50:12 GMT</pubDate>
      <guid>https://www.biospace.com/gtx-inc-and-merck-and-co-inc-in-drug-venture-to-treat-age-related-muscle-loss-b-gtx-b-to-receive-40-million-upfront</guid>
    </item>
    <item>
      <title>Addex Pharmaceuticals Signs $170.5M Deal with Merck &amp; Co., Inc. (Jobs), Shares Rise</title>
      <link>https://www.biospace.com/addex-pharmaceuticals-signs-170-5m-deal-with-merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-2</link>
      <description />
      <pubDate>Mon, 03 Dec 2007 17:14:30 GMT</pubDate>
      <guid>https://www.biospace.com/addex-pharmaceuticals-signs-170-5m-deal-with-merck-and-co-inc-a-href-http-careers-biospace-com-jobs-public-viewcompanyprofile-aspx-company-id-2</guid>
    </item>
  </channel>
</rss>
